Inventor · disambiguated record
Kenichi Washizuka
Also filed as: WASHIZUKA KENICHI
6 granted patents·7 pending applications·13 citations·filing 1990–2018
73Inventor score
Top patents by PatentIndex Score
13 records- 0173US11414429B2Compound or pharmaceutically acceptable salt thereofRIKEN·Filed 2017·Granted Aug 16, 2022·2 cites·16 claims
- 0267US7417060B2Aminoalcohol derivativesASTELLAS PHARMA INC·Filed 2004·Granted Aug 26, 2008·5 cites·16 claims
- 0348US5241064AEnzymatic process for preparing optically active 3-substituted azetidinonesFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Aug 31, 1993·6 cites·4 claims
- 0447US2007142638A1Ornithine derivatives as prostaglandin e2 agonists or antagonistsASTELLAS PHARMA INC·Filed 2004·Application pending·0 cites
- 0545US2005043358A1Aminoalcohol derivatives and their use as beta 3 adrenergic agonistsFUJISAWA PHARMACEUTICAL CO·Filed 2003·Application pending·0 cites
- 0644US2021060016A1Anticancer agentJAPANESE FOUND FOR CANCER RES·Filed 2018·Application pending·0 cites
- 0742US2002143034A1Aminoalcohol derivatives and their use as beta 3 adrenergic agonistsFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 0841US7928264B2Aminoalcohol derivativesASTELLAS PHARMA INC·Filed 2005·Granted Apr 19, 2011·0 cites·27 claims
- 0940US11566017B2Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitorRIKEN·Filed 2018·Granted Jan 31, 2023·0 cites·24 claims
- 1039US6826033B2Aminoalcohol derivativesFUJISAWA PHARMACEUTICAL CO·Filed 2001·Granted Nov 30, 2004·0 cites·9 claims
- 1136US2003032834A1Aminoalcohol derivativesFiled 2001·Application pending·0 cites
- 1235US2003073846A1Aminoalcohol derivativesFiled 2001·Application pending·0 cites
- 1335US2004138462A1Aminoalcohol derivativesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenichi Washizuka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →